Cargando…

Fasting Plasma GLP-1 Is Associated With Overweight/Obesity and Cardiometabolic Risk Factors in Children and Adolescents

CONTEXT: The importance of fasting glucagon-like peptide-1 (GLP-1) in altered metabolic outcomes has been questioned. OBJECTIVE: This work aimed to assess whether fasting GLP-1 differs in children and adolescents with overweight/obesity compared to a population-based reference, and whether concentra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stinson, Sara E, Jonsson, Anna E, Lund, Morten A V, Frithioff-Bøjsøe, Christine, Aas Holm, Louise, Pedersen, Oluf, Ängquist, Lars, Sørensen, Thorkild I A, Holst, Jens J, Christiansen, Michael, Holm, Jens-Christian, Hartmann, Bolette, Hansen, Torben
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118577/ https://www.ncbi.nlm.nih.gov/pubmed/33596309 http://dx.doi.org/10.1210/clinem/dgab098

Ejemplares similares

Hyperglucagonemia in Pediatric Adiposity Associates With Cardiometabolic Risk Factors but Not Hyperglycemia
por: Stinson, Sara E, et al.
Publicado: (2022)

High Plasma Levels of Soluble Lectin‐like Oxidized Low‐Density Lipoprotein Receptor‐1 Are Associated With Inflammation and Cardiometabolic Risk Profiles in Pediatric Overweight and Obesity
por: Stinson, Sara E., et al.
Publicado: (2023)

Glucagon-Like Peptide-1 Is Associated With Systemic Inflammation in Pediatric Patients Treated With Hematopoietic Stem Cell Transplantation
por: Ebbesen, Maria, et al.
Publicado: (2021)

Genetics of Plasma Bilirubin and Associations between Bilirubin and Cardiometabolic Risk Profiles in Danish Children and Adolescents
por: Ullah, Asmat, et al.
Publicado: (2023)

Rare Heterozygous Loss-of-Function Variants in the Human GLP-1 Receptor Are Not Associated With Cardiometabolic Phenotypes
por: Melchiorsen, Josefine U, et al.
Publicado: (2023)

Possible prediction of obesity‐related liver disease in children and adolescents using indices of body composition
por: Johansen, Magnus Jung, et al.
Publicado: (2022)

Obesity treatment effect in Danish children and adolescents carrying Melanocortin-4 Receptor mutations
por: Trier, Cæcilie, et al.
Publicado: (2020)

GLP-1 Receptor Agonist Treatment in Morbid Obesity and Type 2 Diabetes Due to Pathogenic Homozygous Melanocortin-4 Receptor Mutation: A Case Report
por: Iepsen, Eva W., et al.
Publicado: (2020)

Fructose stimulates GLP-1 but not GIP secretion in mice, rats, and humans
por: Kuhre, Rune E., et al.
Publicado: (2014)

Effects of a Family-Based Childhood Obesity Treatment Program on Parental Weight Status
por: Trier, Cæcilie, et al.
Publicado: (2016)

Dyslipidemia and reference values for fasting plasma lipid concentrations in Danish/North-European White children and adolescents
por: Nielsen, Tenna Ruest Haarmark, et al.
Publicado: (2017)

Endurance Training Improves GLP-1 Sensitivity and Glucose Tolerance in Overweight Women
por: Åkerström, Thorbjörn, et al.
Publicado: (2022)

Increased oral sodium chloride intake in humans amplifies selectively postprandial GLP‐1 but not GIP, CCK, and gastrin in plasma
por: Asmar, Ali, et al.
Publicado: (2020)

Increased Body Weight and Fat Mass After Subchronic GIP Receptor Antagonist, but Not GLP-2 Receptor Antagonist, Administration in Rats
por: Baldassano, Sara, et al.
Publicado: (2019)

Smoking during pregnancy is associated with child overweight independent of maternal pre-pregnancy BMI and genetic predisposition to adiposity
por: Schnurr, Theresia M., et al.
Publicado: (2022)

Multidisciplinary care of obese children and adolescents for one year reduces ectopic fat content in liver and skeletal muscle
por: Fonvig, Cilius Esmann, et al.
Publicado: (2015)

A hospital-based child and adolescent overweight and obesity treatment protocol transferred into a community healthcare setting
por: Mollerup, Pernille Maria, et al.
Publicado: (2017)

Plasma levels of glucagon but not GLP-1 are elevated in response to inflammation in humans
por: Modrzynska, Justyna, et al.
Publicado: (2021)

The Antiresorptive Effect of GIP, But Not GLP‐2, Is Preserved in Patients With Hypoparathyroidism—A Randomized Crossover Study
por: Skov‐Jeppesen, Kirsa, et al.
Publicado: (2021)

Acute effects of glucagon‐like peptide‐1, GLP‐1(9–36 amide), and exenatide on mesenteric blood flow, cardiovascular parameters, and biomarkers in healthy volunteers
por: Bremholm, Lasse, et al.
Publicado: (2017)

Type 2 Diabetes risk alleles in Peptidyl-glycine Alpha-amidating Monooxygenase influence GLP-1 levels and response to GLP-1 Receptor Agonists
por: Umapathysivam, Mahesh M, et al.
Publicado: (2023)

GLP1 and glucagon co-secreting pancreatic neuroendocrine tumor presenting as hypoglycemia after gastric bypass
por: Guimarães, Marta, et al.
Publicado: (2015)

Overweight in childhood of exclusively breastfed infants with a high weight at 5 months
por: Morgen, Camilla S., et al.
Publicado: (2020)

A Pilot Study Showing Acute Inhibitory Effect of GLP‐1 on the Bone Resorption Marker CTX in Humans
por: Nissen, Anne, et al.
Publicado: (2019)

CCK‐1 and CCK‐2 receptor agonism do not stimulate GLP‐1 and neurotensin secretion in the isolated perfused rat small intestine or GLP‐1 and PYY secretion in the rat colon
por: Modvig, Ida M., et al.
Publicado: (2020)

Habitual physical activity is associated with lower fasting and greater glucose-induced GLP-1 response in men
por: Janus, Charlotte, et al.
Publicado: (2019)

Novel agonist and antagonist radioligands for the GLP‐2 receptor. Useful tools for studies of basic GLP‐2 receptor pharmacology
por: Gadgaard, Sarina, et al.
Publicado: (2022)

(1)H‐MRS measured ectopic fat in liver and muscle is associated with the metabolic syndrome in Danish girls but not in boys with overweight and obesity
por: Nissen, A., et al.
Publicado: (2016)

Inconsistencies in dosage practice in children with overweight or obesity: A retrospective cohort study
por: Gade, Christina, et al.
Publicado: (2018)

Non-linear interaction between physical activity and polygenic risk score of body mass index in Danish and Russian populations
por: Borisevich, Dmitrii, et al.
Publicado: (2021)

Common variants in LEPR, IL6, AMD1, and NAMPT do not associate with risk of juvenile and childhood obesity in Danes: a case–control study
por: Hollensted, Mette, et al.
Publicado: (2015)

From the Incretin Concept and the Discovery of GLP-1 to Today's Diabetes Therapy
por: Holst, Jens Juul
Publicado: (2019)

Polymorphisms of Serotonin Receptor 2A and 2C Genes and COMT in Relation to Obesity and Type 2 Diabetes
por: Kring, Sofia I. I., et al.
Publicado: (2009)

GLP-1 and Intestinal Diseases
por: Hunt, Jenna Elizabeth, et al.
Publicado: (2021)

Pharmacokinetics of exogenous GIP(1-42) in C57Bl/6 mice; Extremely rapid degradation but marked variation between available assays
por: Boer, Geke Aline, et al.
Publicado: (2021)

Patients With Long-QT Syndrome Caused by Impaired hERG-Encoded K(v)11.1 Potassium Channel Have Exaggerated Endocrine Pancreatic and Incretin Function Associated With Reactive Hypoglycemia
por: Hyltén-Cavallius, Louise, et al.
Publicado: (2017)

What combines best with GLP-1 for obesity treatment: GIP receptor agonists or antagonists?
por: Holst, Jens Juul
Publicado: (2021)

The role of somatostatin in GLP-1-induced inhibition of glucagon secretion in mice
por: Ørgaard, Anne, et al.
Publicado: (2017)

The Influence of Familial Predisposition to Cardiovascular Complications upon Childhood Obesity Treatment
por: Nielsen, Louise A., et al.
Publicado: (2015)

Impaired glucose metabolism and altered gut microbiome despite calorie restriction of ob/ob mice
por: Kashani, Alireza, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cgejr0luqouic2o8idndd60o4t